Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 889

1.

Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36.

Hsieh J, Longuet C, Maida A, Bahrami J, Xu E, Baker CL, Brubaker PL, Drucker DJ, Adeli K.

Gastroenterology. 2009 Sep;137(3):997-1005, 1005.e1-4. doi: 10.1053/j.gastro.2009.05.051. Epub 2009 May 29.

PMID:
19482026
2.

Glucagon-Like Peptide 2 (GLP-2) Stimulates Postprandial Chylomicron Production and Postabsorptive Release of Intestinal Triglyceride Storage Pools via Induction of Nitric Oxide Signaling in Male Hamsters and Mice.

Hsieh J, Trajcevski KE, Farr SL, Baker CL, Lake EJ, Taher J, Iqbal J, Hussain MM, Adeli K.

Endocrinology. 2015 Oct;156(10):3538-47. doi: 10.1210/EN.2015-1110. Epub 2015 Jul 1.

PMID:
26132919
5.
7.

New and emerging regulators of intestinal lipoprotein secretion.

Xiao C, Dash S, Morgantini C, Lewis GF.

Atherosclerosis. 2014 Apr;233(2):608-15. doi: 10.1016/j.atherosclerosis.2013.12.047. Epub 2014 Jan 21. Review.

PMID:
24534456
8.

Intestinal SR-BI is upregulated in insulin-resistant states and is associated with overproduction of intestinal apoB48-containing lipoproteins.

Hayashi AA, Webb J, Choi J, Baker C, Lino M, Trigatti B, Trajcevski KE, Hawke TJ, Adeli K.

Am J Physiol Gastrointest Liver Physiol. 2011 Aug;301(2):G326-37. doi: 10.1152/ajpgi.00425.2010. Epub 2011 May 5.

9.

Signposts in the assembly of chylomicrons.

Hussain MM, Kedees MH, Singh K, Athar H, Jamali NZ.

Front Biosci. 2001 Mar 1;6:D320-31. Review.

PMID:
11229873
10.

Lipid micelles stimulate the secretion of triglyceride-enriched apolipoprotein B48-containing lipoproteins by Caco-2 cells.

Chateau D, Pauquai T, Delers F, Rousset M, Chambaz J, Demignot S.

J Cell Physiol. 2005 Mar;202(3):767-76.

PMID:
15389567
11.

The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice.

Hsieh J, Longuet C, Baker CL, Qin B, Federico LM, Drucker DJ, Adeli K.

Diabetologia. 2010 Mar;53(3):552-61. doi: 10.1007/s00125-009-1611-5. Epub 2009 Dec 3.

PMID:
19957161
12.

Intestinal lipid absorption, GLP-2, and CD36: still more mysteries to moving fat.

Newberry EP, Davidson NO.

Gastroenterology. 2009 Sep;137(3):775-8. doi: 10.1053/j.gastro.2009.07.034. Epub 2009 Jul 28. No abstract available.

13.

Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans.

Meier JJ, Nauck MA, Pott A, Heinze K, Goetze O, Bulut K, Schmidt WE, Gallwitz B, Holst JJ.

Gastroenterology. 2006 Jan;130(1):44-54.

PMID:
16401467
14.

Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes.

Matikainen N, Mänttäri S, Schweizer A, Ulvestad A, Mills D, Dunning BE, Foley JE, Taskinen MR.

Diabetologia. 2006 Sep;49(9):2049-57. Epub 2006 Jul 1.

PMID:
16816950
15.

CD36 is important for fatty acid and cholesterol uptake by the proximal but not distal intestine.

Nassir F, Wilson B, Han X, Gross RW, Abumrad NA.

J Biol Chem. 2007 Jul 6;282(27):19493-501. Epub 2007 May 15.

16.

GLP-1 reduces intestinal lymph flow, triglyceride absorption, and apolipoprotein production in rats.

Qin X, Shen H, Liu M, Yang Q, Zheng S, Sabo M, D'Alessio DA, Tso P.

Am J Physiol Gastrointest Liver Physiol. 2005 May;288(5):G943-9. Epub 2005 Jan 27.

18.

Intestinal lipid absorption is not affected in CD36 deficient mice.

Goudriaan JR, Dahlmans VE, Febbraio M, Teusink B, Romijn JA, Havekes LM, Voshol PJ.

Mol Cell Biochem. 2002 Oct;239(1-2):199-202.

PMID:
12479586
20.

Supplemental Content

Support Center